Brain Disease Modalities and Software Market, By Product Type (Brain Analysis Software and Brain Imaging Modalities), By Patient Type, By Indication, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Brain Disease Modalities and Software Market size was valued at USD 13,690.32 Million in 2023, expanding at a CAGR of 5.90% from 2024 to 2032.
The diagnosis of brain diseases through the use of multiple imaging modalities has demonstrated enhanced effectiveness when compared to the application of a single modality. However, the availability of multi-modal data in clinical practice is often limited due to financial constraints or the associated risks of radiation exposure. The modalities and software utilized for brain disease encompass a diverse range of technologies and applications aimed at diagnosing, monitoring, and treating various neurological disorders. These tools are vital in contemporary neurology, offering extensive diagnostic capabilities, supporting research initiatives, and improving treatment and rehabilitation results for patients suffering from neurological conditions.
Brain Disease Modalities and Software Market- Market Dynamics
The increasing prevalence of neurological disorders and demands for safer and non-invasive imaging devices is expected to drive the growth of the market
With the aging of the global population, there is a notable rise in the prevalence of neurological disorders, including Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and epilepsy. This expanding demographic of patients necessitates the development of sophisticated diagnostic and therapeutic approaches. In 2021, neurological disorders accounted for 443 million years of healthy life lost due to illness, disability, and premature mortality (measured in disability-adjusted life years), positioning them as the leading cause of the global disease burden, surpassing cardiovascular diseases, as reported by the Institute for Health Metrics and Evaluation. Non-invasive imaging techniques, such as MRI and PET scans, present a safer alternative to invasive methods, minimizing the risk of complications and discomfort for patients, which in turn promotes their wider acceptance. Additionally, advancements in imaging technologies, including high-resolution MRI, functional MRI (fMRI), and enhanced PET scans, create opportunities for the Brain Disease Modalities and Software market. However, limited awareness and accessibility may pose challenges to the market\'s growth.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BRAIN DISEASE MODALITIES AND SOFTWARE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Quantib
Brainomix
Qure.ai
GE Company
Imaging Biometrics, LLC
United Imaging Healthcare Co. Ltd.
Siemens
Healthineers AG
KONINKLIJKE PHILIPS ELECTRONICS NV
Canon Inc.
VUNO Inc.
Aspect Imaging
IXICO
QMENTA
Cortechs.ai
A.I. Analysis, Inc.
FUJIFILM Holdings Corporation
Others
GLOBAL BRAIN DISEASE MODALITIES AND SOFTWARE MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
Brain Analysis Software
Brain Imaging Modalities
o CT Devices
o MRI Devices
o PET Devices
o PET-CT
o PET-MRI
GLOBAL BRAIN DISEASE MODALITIES AND SOFTWARE MARKET, BY PATIENT TYPE- MARKET ANALYSIS, 2019 - 2032
Adults
Infants
Pediatrics
GLOBAL BRAIN DISEASE MODALITIES AND SOFTWARE MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032
Traumatic Brain Injury (TBI)
Headache disorders
Epilepsy
Sleep disorders
Parkinson\'s disease
Stroke
Huntington\'s disease
Dementia
GLOBAL BRAIN DISEASE MODALITIES AND SOFTWARE MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
Hospitals and Clinics
Ambulatory Surgery Centers
Diagnostic Imaging Centers
GLOBAL BRAIN DISEASE MODALITIES AND SOFTWARE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
o The U.S.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Brain Disease Modalities and Software Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Brain Disease Modalities and Software Market Snippet by Product Type
2.1.2. Brain Disease Modalities and Software Market Snippet by Patient Type
2.1.3. Brain Disease Modalities and Software Market Snippet by Indication
2.1.4. Brain Disease Modalities and Software Market Snippet by End-User
2.1.5. Brain Disease Modalities and Software Market Snippet by Country
2.1.6. Brain Disease Modalities and Software Market Snippet by Region
2.2. Competitive Insights
3. Brain Disease Modalities and Software Key Market Trends
3.1. Brain Disease Modalities and Software Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Brain Disease Modalities and Software Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Brain Disease Modalities and Software Market Opportunities
3.4. Brain Disease Modalities and Software Market Future Trends
4. Brain Disease Modalities and Software Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Brain Disease Modalities and Software Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Brain Disease Modalities and Software Market Landscape
6.1. Brain Disease Modalities and Software Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Brain Disease Modalities and Software Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
7.1.2. Brain Analysis Software
7.1.3. Brain Imaging Modalities
7.1.3.1. CT Devices
7.1.3.2. MRI Devices
7.1.3.3. PET Devices
7.1.3.4. PET-CT
7.1.3.5. PET-MRI
8. Brain Disease Modalities and Software Market – By Patient Type
8.1. Overview
8.1.1. Segment Share Analysis, By Patient Type, 2023 & 2032 (%)
8.1.2. Adults
8.1.3. Infants
8.1.4. Paediatrics
9. Brain Disease Modalities and Software Market – By Indication
9.1. Overview
9.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
9.1.2. Traumatic Brain Injury (TBI)
9.1.3. Headache disorders
9.1.4. Epilepsy
9.1.5. Sleep disorders
9.1.6. Parkinson\'s disease
9.1.7. Stroke
9.1.8. Huntington\'s disease
9.1.9. Dementia
10. Brain Disease Modalities and Software Market – By End-User
10.1. Overview
10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
10.1.2. Hospitals and Clinics
10.1.3. Ambulatory Surgery Centers
10.1.4. Diagnostic Imaging Centers
11. Brain Disease Modalities and Software Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Brain Disease Modalities and Software Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Brain Disease Modalities and Software Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.9. Italy
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.9.4. Italy Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.3.9.5. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.10. United Kingdom
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.10.4. United Kingdom Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.3.10.5. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.11. France
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.11.4. France Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.3.11.5. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.12. Russia
11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.12.3. Russia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.3.12.4. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.13. Netherlands
11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.13.3. Netherlands Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.3.13.4. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.15. Poland
11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.15.3. Poland Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.3.15.4. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.16. Rest of Europe
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.16.4. Rest of the Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.3.16.5. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Brain Disease Modalities and Software Key Manufacturers in Asia Pacific
11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.5. Asia Pacific Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.4.6. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.8. India
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.8.4. India Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.4.8.5. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.9. China
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.9.4. China Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.4.9.5. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.13. Thailand
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.13.4. Thailand Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.4.13.5. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.14. Indonesia
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.14.4. Indonesia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.4.14.5. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5. Latin America
11.5.1. Overview
11.5.2. Brain Disease Modalities and Software Key Manufacturers in Latin America
11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.5. Latin America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.5.6. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa
11.6.1. Overview
11.6.2. Brain Disease Modalities and Software Key Manufacturers in Middle East and Africa
11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.5. Middle East and Africa Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.6.6. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Brain Disease Modalities and Software Industry
12.1. Competitive Dashboard
12.2. Company Profiles
12.2.1. Quantib
12.2.2. Brainomix
12.2.3. Qure.ai
12.2.4. GE Company
12.2.5. Imaging Biometrics, LLC
12.2.6. United Imaging Healthcare Co. Ltd.
12.2.7. Siemens
12.2.8. Healthineers AG
12.2.9. KONINKLIJKE PHILIPS ELECTRONICS NV
12.2.10. Canon Inc.
12.2.11. VUNO Inc.
12.2.12. Aspect Imaging
12.2.13. IXICO
12.2.14. QMENTA
12.2.15. Cortechs.ai
12.2.16. A.I. Analysis, Inc.
12.2.17. FUJIFILM Holdings Corporation
12.2.18. Others
13. 360 Degree Analyst View
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
